Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Mitali, Pandey"'
Publikováno v:
Pharmaceutics, Vol 13, Iss 9, p 1509 (2021)
There have been several studies that have linked elevated scavenger receptor class b type 1 (SR-B1) expression and activity to the development and progression of castration-resistant prostate cancer (CRPC). SR-B1 facilitates the influx of cholesterol
Externí odkaz:
https://doaj.org/article/c572c409c9c144f288db844464ca3bfd
Publikováno v:
Frontiers in Genetics, Vol 10 (2019)
Prostate cancer remains a major public health problem and the second leading cause of cancer-related deaths in men in the United States. The present study aims to understand the molecular pathway(s) of prostate cancer which is essential for early det
Externí odkaz:
https://doaj.org/article/055dce1f8b124623b8c93e8b165bfac4
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0224071 (2019)
Dysregulation of miRNAs has been demonstrated in several human malignancies including prostate cancer. Due to tissue limitation and variable disease progression, stage-specific miRNAs changes in prostate cancer is unknown. Using chip-based microarray
Externí odkaz:
https://doaj.org/article/4c64bb8cf43c4db2aebecb41288d8184
Autor:
Michael E. Cox, Alexander Levitzki, Martin E. Gleave, Haruhito Azuma, Ladan Fazli, Mitali Pandey, Hadas Reuveni, Mazyar Ghaffari, Naokazu Ibuki
Supplementary Table and Figures: Table S1: Prostate cancer tumor microarray characteristics Fig. S1: IRS antibody validation Fig. S2: Effect of NT157 on the viability of benign prostatic cell line Fig. S3: Immunoblot analysis of cell cycle markers Fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12899b36d256a918f07acb7d5c019e70
https://doi.org/10.1158/1535-7163.22502218
https://doi.org/10.1158/1535-7163.22502218
Autor:
Felipe Eltit, Nicole Robinson, Pak Lok Ivan Yu, Mitali Pandey, Jerome Lozada, Yubin Guo, Manju Sharma, Dogancan Ozturan, Laetitia Ganier, Eric Belanger, Nathan A. Lack, David M. Perrin, Michael E. Cox, S. Larry Goldenberg
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783031261626
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7985325a1ca38d2208c4de6e0aed181
https://doi.org/10.1007/978-3-031-26163-3_16
https://doi.org/10.1007/978-3-031-26163-3_16
Autor:
Mitali Pandey Minare
Publikováno v:
ShodhKosh: Journal of Visual and Performing Arts. 1:1-13
The world of arts and handicrafts represents a great saga of culture, traditions and historical legacy associated with each particular region. India, in general and Madhya Pradesh, in particular are known for the impressive range of hand-made artifac
Autor:
Mario Candamo, Sanjeev Shukla, Sanjay Gupta, Shiv Verma, Rajnee Kanwal, Eswar Shankar, Mitali Pandey, Ata Abbas, Gregory T. MacLennan
Publikováno v:
Mol Carcinog
Maspin repression is frequently observed in prostate cancer; however, the molecular mechanism(s) causing the loss is not completely understood. Here, we demonstrate that inhibition of class I histone deacetylases (HDACs) mediates re-expression of mas
Publikováno v:
Pharmaceutics
Pharmaceutics, Vol 13, Iss 1509, p 1509 (2021)
Pharmaceutics, Vol 13, Iss 1509, p 1509 (2021)
There have been several studies that have linked elevated scavenger receptor class b type 1 (SR-B1) expression and activity to the development and progression of castration-resistant prostate cancer (CRPC). SR-B1 facilitates the influx of cholesterol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da2f8df8a485bcc3111cc47dd416a8dc
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 11, p e0224071 (2019)
PLoS ONE, Vol 14, Iss 11, p e0224071 (2019)
Dysregulation of miRNAs has been demonstrated in several human malignancies including prostate cancer. Due to tissue limitation and variable disease progression, stage-specific miRNAs changes in prostate cancer is unknown. Using chip-based microarray
Publikováno v:
Cancer Research. 79:4347-4347
Prostate cancer remains a major public health problem and second leading cause of cancer-related deaths in men in the United States. Despite widespread screening efforts and advancement in therapeutic regimens, incidence of prostate cancer remains st